Adcock Ingram Holdings Ltd (AIP) - Financial and Strategic SWOT Analysis Review

October 2021 | 41 pages | ID: A79BCE386E5EN
GlobalData

Abstracts

Adcock Ingram Holdings Ltd (AIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Adcock Ingram Holdings Ltd (Adcock Ingram) develops, distributes and markets a wide range of healthcare products. The company’s product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It provides medicines in the areas of cardiovascular, central nervous system, cough, cold and flu, skin care, diabetes, ear, nose and eye preparations, feminine health, pain and respiratory diseases among others. Adcock Ingram also supplies critical care products, including blood collection products, intravenous solutions and renal dialysis systems. It has three manufacturing facilities in South Africa and a manufacturing facility (joint venture) in Bangalore, India. The company supplies its products to both the private and public sectors of the market. Adcock Ingram is headquartered in Johannesburg, South Africa.

Adcock Ingram Holdings Ltd Key Recent Developments

Feb 24,2021: The Adcock Ingram reports a resilient trading performance for the six-months ended 31 December 2020
Aug 26,2020: Adcock Ingram reports satisfying results
Feb 20,2020: The Adcock Ingram Group reports a reasonable set of results in a difficult market for the six-months ended 31 December 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Adcock Ingram Holdings Ltd - Key Facts
Adcock Ingram Holdings Ltd - Key Employees
Adcock Ingram Holdings Ltd - Key Employee Biographies
Adcock Ingram Holdings Ltd - Major Products and Services
Adcock Ingram Holdings Ltd - History
Adcock Ingram Holdings Ltd - Company Statement
Adcock Ingram Holdings Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Adcock Ingram Holdings Ltd - Business Description
Business Segment: Southern Africa
Overview
Performance
Adcock Ingram Holdings Ltd - Corporate Strategy
Adcock Ingram Holdings Ltd - SWOT Analysis
SWOT Analysis - Overview
Adcock Ingram Holdings Ltd - Strengths
Adcock Ingram Holdings Ltd - Weaknesses
Adcock Ingram Holdings Ltd - Opportunities
Adcock Ingram Holdings Ltd - Threats
Adcock Ingram Holdings Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Adcock Ingram Holdings Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 24, 2021: The Adcock Ingram reports a resilient trading performance for the six-months ended 31 December 2020
Aug 26, 2020: Adcock Ingram reports satisfying results
Feb 20, 2020: The Adcock Ingram Group reports a reasonable set of results in a difficult market for the six-months ended 31 December 2019

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Adcock Ingram Holdings Ltd, Key Facts
Adcock Ingram Holdings Ltd, Key Employees
Adcock Ingram Holdings Ltd, Key Employee Biographies
Adcock Ingram Holdings Ltd, Major Products and Services
Adcock Ingram Holdings Ltd, History
Adcock Ingram Holdings Ltd, Subsidiaries
Adcock Ingram Holdings Ltd, Joint Venture
Adcock Ingram Holdings Ltd, Key Competitors
Adcock Ingram Holdings Ltd, Ratios based on current share price
Adcock Ingram Holdings Ltd, Annual Ratios
Adcock Ingram Holdings Ltd, Annual Ratios (Cont...1)
Adcock Ingram Holdings Ltd, Annual Ratios (Cont...2)
Adcock Ingram Holdings Ltd, Interim Ratios
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Adcock Ingram Holdings Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Adcock Ingram Holdings Ltd, Performance Chart (2017 - 2021)
Adcock Ingram Holdings Ltd, Ratio Charts
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021